AbbVie and Google's Calico strike $1.5bn age-related drug deal

AbbVie and Google's mysterious life sciences company Calico announced a plan to co-invest up to $1.5bn in a research collaboration to develop new therapies that treat age-related diseases, including neurodegeneration and cancer.